Cleared Traditional

K200606 - O-Genesis Graft Delivery System

K200606 is the FDA 510(k) clearance for O-Genesis Graft Delivery System by Orthofix, Inc.. It is a Class 2 General & Plastic Surgery device (product code FMF) cleared through the Traditional 510(k) pathway after a 53-day FDA review.

K200606 · Orthofix, Inc. · General & Plastic Surgery device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
May 2020
Decision
53d
Days
Class 2
Risk

K200606 is an FDA 510(k) clearance for the O-Genesis Graft Delivery System. Classified as Syringe, Piston (product code FMF), Class II - Special Controls.

Submitted by Orthofix, Inc. (Lewisville, US). The FDA issued a Cleared decision on May 1, 2020 after a review of 53 days - a notably fast clearance cycle.

This device falls under the General & Plastic Surgery FDA review panel, regulated under 21 CFR 880.5860 - the FDA general and plastic surgery device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Orthofix, Inc. devices

Submission Details

510(k) Number K200606 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received March 09, 2020
Decision Date May 01, 2020
Days to Decision 53 days
Submission Type Traditional
Review Panel General & Plastic Surgery (SU)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
62d faster than avg
Panel avg: 115d · This submission: 53d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code FMF Syringe, Piston
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 880.5860
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General & Plastic Surgery devices follow this clearance model.

Regulatory Peers - FMF Syringe, Piston

All 287
Devices cleared under the same product code (FMF) and FDA review panel - the closest regulatory comparables to K200606.
Allograft MIS Delivery System
K201338 · Lifenet Health · Jul 2020
Aspire Mechanical Aspirator G
K200629 · Control Medical Technology · May 2020
3D GraftRasp System
K200431 · Surgentec · May 2020
Omnifix Low Dead Space Luer Lock Syringe
K193101 · B.Braun Medical, Inc. · Mar 2020
Mixing and Delivery System
K192674 · Bone Solutions, Inc. · Feb 2020
Tamper Evident Cap
K193192 · International Medical Industries, Inc. · Jan 2020